(NASDAQ: WBA) Walgreens Boots Alliance's forecast annual revenue growth rate of 1.86% is forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 1.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.84%.
Walgreens Boots Alliance's revenue in 2025 is $151,945,000,000.On average, 6 Wall Street analysts forecast WBA's revenue for 2025 to be $130,995,361,804,454, with the lowest WBA revenue forecast at $129,046,092,982,706, and the highest WBA revenue forecast at $133,094,404,094,874. On average, 6 Wall Street analysts forecast WBA's revenue for 2026 to be $133,002,322,479,805, with the lowest WBA revenue forecast at $124,180,645,199,609, and the highest WBA revenue forecast at $136,038,836,637,564.
In 2027, WBA is forecast to generate $140,406,825,785,341 in revenue, with the lowest revenue forecast at $139,774,260,500,837 and the highest revenue forecast at $141,151,685,933,279.